These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3522415)

  • 21. Antilymphocyte serum: studies of the specificity of the rosette-inhibiting antibody in rabbit anti-mouse ALS.
    Morton H; Hegh V; Clunie GJ
    Aust J Exp Biol Med Sci; 1976 Oct; 53(5):373-80. PubMed ID: 779745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of skin allografts after oral application of ALS in rats.
    Seifert J; Ring J; Brendel W
    Nature; 1974 Jun; 249(459):776. PubMed ID: 4599458
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of C-type viruses during skin graft rejection in the mouse. Interrelationships between immunostimulation and immunosuppression.
    Hirsch MS; Ellis DA; Kelly AP; Proffitt MR; Black PH; Monaco AP; Wood ML
    Int J Cancer; 1975 Mar; 15(3):493-502. PubMed ID: 166935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.
    Rieger M; Hilgert I; Kristofová H; Vlachov K
    Folia Biol (Praha); 1979; 25(4):220-30. PubMed ID: 159195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of bacterial adjuvants on allograft survival after anti-lymphocyte serum (ALS) and donor bone marrow in mice.
    Clark AW; Monaco AP
    Immunology; 1974 Nov; 27(5):887-93. PubMed ID: 4373388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked prolongation of rat skin xenografts induced by intrathymic injection of xenogeneic splenocytes and a short course of rapamycin in antilymphocyte serum-treated mice.
    Dono K; Wood ML; Ozato H; Otsu I; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1995 Apr; 59(7):929-32. PubMed ID: 7709451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells.
    De Fazio SR; Masli S; Gozzo JJ
    Transplantation; 1996 Jan; 61(1):104-10. PubMed ID: 8560547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC; Markees TG; De Fazio SR; Khouri W; Maki T; Monaco AP; Gozzo JJ
    Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice.
    Wood ML; Monaco AP; Gottschalk R
    Transplantation; 1991 Jan; 51(1):208-13. PubMed ID: 1670969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antilymphocyte serum and cyclophosphamide in the induction of tolerance to skin allografts in guinea pigs.
    Polak L; Frey JR; Turk JL
    Transplantation; 1972 Mar; 13(3):310-5. PubMed ID: 4553732
    [No Abstract]   [Full Text] [Related]  

  • 36. "In vivo" standardization model for defining the dose-response-dependent graft-protective value of antilymphocyte sera.
    Réthy L; Osz E
    Dev Biol Stand; 1974; 27():233-5. PubMed ID: 4618536
    [No Abstract]   [Full Text] [Related]  

  • 37. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
    Kanamoto A; Monaco AP; Maki T
    Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum.
    Cinader B; Jeejeebhoy HF; Koh SW; Rabbat AG
    J Exp Med; 1971 Jan; 133(1):81-99. PubMed ID: 4924199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted to rat leukocyte membranes.
    Fabre JW; Sunderland CA; Williams AF
    Transplantation; 1980 Sep; 30(3):167-73. PubMed ID: 14582171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1979 Nov; 28(5):387-8. PubMed ID: 160636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.